Let's make poor reporting of early phase dose finding clinical trials a thing of the past

被引:0
|
作者
Yap, Christina [1 ]
机构
[1] Inst Canc Res, Clin Trials & Stat Unit, London, England
来源
BMJ-BRITISH MEDICAL JOURNAL | 2023年 / 383卷
关键词
D O I
10.1136/bmj.p2865
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [21] Reporting quality of CONSORT flow diagrams in published early phase dose-finding clinical trial reports: Improvement is needed
    Alger, Emily
    Zhang, Yuqi
    Yap, Christina
    CONTEMPORARY CLINICAL TRIALS, 2023, 131
  • [22] Assessing the reporting quality of early phase dose-finding trial protocols: a methodological review
    Villacampa, Guillermo
    Patel, Dhrusti
    Zheng, Haiyan
    McAleese, Jessica
    Rekowski, Jan
    Solovyeva, Olga
    Yin, Zhulin
    Yap, Christina
    ECLINICALMEDICINE, 2023, 60
  • [23] Bayesian hybrid dose-finding design in phase I oncology clinical trials
    Yuan, Ying
    Yin, Guosheng
    STATISTICS IN MEDICINE, 2011, 30 (17) : 2098 - 2108
  • [24] A dose-schedule finding design for phase I-II clinical trials
    Guo, Beibei
    Li, Yisheng
    Yuan, Ying
    JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES C-APPLIED STATISTICS, 2016, 65 (02) : 259 - 272
  • [25] Dose-finding in phase I clinical trials based on toxicity probability intervals
    Ji, Yuan
    Li, Yisheng
    Bekele, B. Nebiyou
    CLINICAL TRIALS, 2007, 4 (03) : 235 - 244
  • [26] Finding Maximum Tolerated Dose in Phase I Oncology Clinical Trials with Bayesian Methods
    Sapi, Johanna
    ACTA POLYTECHNICA HUNGARICA, 2024, 21 (06) : 129 - 145
  • [27] Competing designs for drug combination in phase I dose-finding clinical trials
    Riviere, M. -K.
    Dubois, F.
    Zohar, S.
    STATISTICS IN MEDICINE, 2015, 34 (01) : 1 - 12
  • [28] Innovations for phase I dose-finding designs in pediatric oncology clinical trials
    Doussau, Adelaide
    Geoerger, Birgit
    Jimenez, Irene
    Paoletti, Xavier
    CONTEMPORARY CLINICAL TRIALS, 2016, 47 : 217 - 227
  • [29] Bayesian dose finding in phase I clinical trials based on a new statistical framework
    Ji, Y.
    Li, Y.
    Yin, G.
    STATISTICA SINICA, 2007, 17 (02) : 531 - 547
  • [30] A robust Bayesian dose-finding design for phase I/II clinical trials
    Liu, Suyu
    Johnson, Valen E.
    BIOSTATISTICS, 2016, 17 (02) : 249 - 263